Zhitong Finance App News, Ganli Pharmaceutical (603087.SH) issued an announcement. Recently, the company received approval for the registration of insulin glargine injection (cartridge) (approval number: BT004315102026) from the General Administration of Health Supervision of El Salvador. Indications: Used for diabetes treatment in adults, adolescents and children aged 2 and above.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.